Aarey Drugs & Pharmaceuticals’ board has approved the issue price of Rs 54.93 per Equity share (including premium of Rs 44.93 per Equity share) for issuance & allocation of 33,00,000 Equity shares to eligible Qualified Institutional Buyers in the Qualified Institutional Placement, aggregating to Rs 18.13 crore. The Board of directors of the bank at its meeting held on March 20, 2018 approved the same.
Aarey Drugs & Pharmaceuticals is engaged in the manufacturing of drugs and intermediates such as metronidazole, metronidazole benzoate, methyl, and nitro imidazole. The company is based in Thane, India.
